The pharmaco-invasive approach to STEMI: When should fibrinolytic-treated patients go to the "cath lab"?

Postgraduate Medical Journal

Volumn 85, Issue 1004, 2009, Pages 331-334

  Edmond, J J ^a   Juergens, C P ^b   French, J K ^b  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b LIVERPOOL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; RETEPLASE; STREPTOKINASE; TENECTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ANGIOPLASTY; BLEEDING; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY ARTERY SURGERY; EVENT FREE SURVIVAL; FIBRINOLYSIS; HEART INFARCTION; HUMAN; MORTALITY; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; REPERFUSION; REVIEW; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; EMERGENCY MEDICAL SERVICES; FIBRINOLYTIC AGENTS; HOSPITALIZATION; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PATIENT SELECTION; REFERRAL AND CONSULTATION; TIME FACTORS; TREATMENT FAILURE;

EID: 67649836348     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/hrt.2007.137182     Document Type: Review

References (46)

1. Wong CK, Gao WZ, Raffel OC, et al. Initial Q waves accompanying ST segment-elevation at presentation of acute myocardial infarction and 30-day mortality in patients given streptokinase therapy: analysis from HERO-2. Lancet 2006;367:2061-2067 (Pubitemid 43913985)
2. French JK, Andrews J, Manda S, et al. Early ST segment recovery, infarct artery blood flow, and long-term outcome after acute myocardial infarction. Am Heart J 2002;143:265-271
3. Toma M, Fu Y, Wagner G, et al. Risk stratification in ST elevation myocardial infarction is enhanced by combining baseline ST deviation and subsequent ST segment resolution. Heart 2008;94:e6.
4. Schroder K, Wegscheider K, Zeymer U, et al. Extent of ST-segment deviation in a single electrocardiogram lead 90 min after thrombolysis as a predictor of medium-term mortality in acute myocardial infarction. Lancet 2001;358:1479-1486 (Pubitemid 33055698)
5. Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-322 (Pubitemid 124000789)
6. Keeley E, Boura J, Grines C. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantative review of 23 randomised trials. Lancet 2003;361:13-20. (Pubitemid 36050955)
7. Nallamothu B, Bradley E, Kruhholz H. Time to treatment in primary percutaneous coronary intervention. N Engl J Med 2007;357:1631-1638 (Pubitemid 47598405)
8. Brophy J. Has thrombolysis lost its mojo? Heart 2007;93:1167-1169
9. Bjorklund E, Stenestrand U, Lindback J, et al. Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction. Eur Heart J 2006;283:1146-1152 (Pubitemid 43752384)
10. Morrison L, Verbeek P, McDonald A, et al. Mortality and prehospital thrombolysis for acute myocardial infarction. JAMA 2000;283:2686-2692 (Pubitemid 30337331)
11. Danchin N, Blanchard D, Steg P, et al. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French nationwide USIC 2000 Registry. Circulation 2004;110:1909-1915
12. Bonnefoy E, Lapostolle F, Leizorovicz A, et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 2002;360:825-829 (Pubitemid 35257945)
13. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) Investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 2006;367:569-578
14. The Apex AMI Investigators. Prexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention. a randomized controlled trial. JAMA 2007;297:43-51.
15. Ting HH, Krumholz HM, Bradley EH, et al. Implementation and integration of prehospital ECGs into systems of care for acute coronary syndome. A scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, Emergency Cardiovascular Care Committee, Council on Cardiovascular Nursing, and Council on Clinical Cardiology. Circulation 2008 Aug 13. [Epub ahead of print].
16. Ellis S, De Vivie E, Spaulding CM, et al. Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences. Am Heart J 2000;139:1046-1053
17. Wijeysundera H, Vijayaraghavan R, Nallamothu B, et al. Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: a meta-analysis of randomized trials. J Am Coll Cardiol 2007;49:422-430 (Pubitemid 46156979)
18. Sutton A, Campbell P, Graham R, et al. A randomised trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-elevation myocardial infarction. The Middlesbrough Early Revascularisation to Limit INfarction (MERLIN) Trial. J Am Coll Cardiol 2004;44:287-296 (Pubitemid 38950584)
19. Gershlick A, Stephens-Lloyd A, Hughes S, et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med 2005;353:2758-2768 (Pubitemid 43016815)
20. Hsieh V, Wouter N, Van der Vijer R, et al. Late clinical outcomes after rescue PCI - 5 years experience from a regional cardiac centre. Heart Lung and Circulation 2006;15:S138.
21. Keeley E, Boura J, Grines C. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantative review of randomised trials. Lancet 2006;367:579-588 (Pubitemid 43247573)
22. Andersen H, Nielsen T, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733-742 (Pubitemid 37010777)
23. Lo TSN, Hall IR, Jaumdally R, et al. Transradial rescue angioplasty for failed thrombolysis in acute myocardial infarction: reperfusion with reduced vascular risk. Heart 2006;92:1153-1154 (Pubitemid 44125246)
24. Gilchrist IC, French JK. Radial access for cardiac catheterisation is not radical. Am Heart J (in press).
25. Ganz W, Buchbinder N, Marcus H, et al. Intracoronary thrombolysis in evolving myocardial infarction. Am Heart J 1981;101:4-13. (Pubitemid 11213429)
26. Rentrop P, Blanke H, Karsch K, et al. Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation 1981;63:307-317 (Pubitemid 11168747)
27. Califf R, O'Neil W, Stack R, et al. Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. Ann Intern Med 1988;108:658-662 (Pubitemid 18110936)
28. Shah P, Cercek B, Lew A, et al. Angiographic validation of bedside markers of reperfusion. J Am Coll Cardiol 1993;21:55-61. (Pubitemid 23031295)
29. de Lemos J, Antman E, Giugliano R, et al. ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Am J Cardiol 2000;85:299-304. (Pubitemid 30052900)
30. Zeymer U, Schroder R, Tebbe U, et al. Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction; results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 trial. Eur Heart J 2001;22:769-775 (Pubitemid 32625233)
31. Andrews J, Straznicky IT, French J, et al. ST-segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapy. Circulation 2000;101:2138-2143 (Pubitemid 30253040)
32. Roe MT, Ohman EM, Maas ACP, et al. Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. J Am Coll Cardiol 2001;37:9-18. (Pubitemid 32051713)
33. Stewart JT, French JK, Thèroux P, et al. Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction. J Am Coll Cardiol 1998;31:1499-1505 (Pubitemid 28273290)
34. Tanasijevic MJ, Cannon CP, Antman EM, et al. Myoglobin, creatine-kinase-MB and cardiac troponin-I-60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis In Myocardial Infarction study (TIMI) 10B. J Am Coll Cardiol 1999;34:739-747 (Pubitemid 29436179)
35. French JK, Ramanathan K, Stewart JT, et al. A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction. Am Heart J 2003;145:508-514 (Pubitemid 36390498)
36. Fernandez-Aviles F, Alonso J, Pena G, et al. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. Eur Heart J 2007;28:949-960 (Pubitemid 47343896)
37. French JK, Feldman HA, Assmann SF, et al. For the SHOCK Investigators. Thrombolytic therapy with or without intra-aortic balloon counter-pulsation is associated with increased 12-month survival in the SHOCK Trial. Am Heart J 2003;146:804-810
38. Ellis SG, Tendera M, de Belder MA, et al. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med 2008;358:2205-2217
39. Silber S, Albertsson P, Avilés FF, et al. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J 2005;26:804-847 (Pubitemid 40547082)
40. Tobing D, French J, Varigos J, et al. For the post-MI audit group. Do patients with heart failure appropriately undergo invasive procedures post myocardial infarction? Results from a prospective multi-centre study. Intern Med J 2008 Apr 4. [Epub ahead of print].
41. Armstrong P. WEST Steering Committee. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study. Eur Heart J 2006;27:1530-1538 (Pubitemid 43954910)
42. Fernandez-Aviles F, Alonso J, Castro-Beiras A, et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial. Lancet 2004;364:1045-1053 (Pubitemid 39248663)
43. Di Mario C, Dudek D, Piscione F, et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet 2008;371:559-568
44. Henry T, Sharkey S, Burke M, et al. A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction. Circulation 2007;116:721-728 (Pubitemid 47255989)
45. Ting H, Rihal C, Gersh B, et al. Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol. Circulation 2007;116:729-736 (Pubitemid 47255990)
46. Jollis JG, Roettig ML, Aluko AO, et al. Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction. JAMA 2007;298:2371-2380 (Pubitemid 350190778)